Rural Health
News by Topic: Substance use and misuse
Nov 12, 2026 - Describes the planned work of a Substance Abuse and Mental Health Services Administration (SAMHSA)-funded center in the Northeast to provide training and technical assistance to healthcare providers in the region on topics related to rural substance use prevention, treatment, and recovery. Discusses how the initiative will use partnerships to involve community organizations, healthcare providers, and other stakeholders in driving the work of the group.
Nov 8, 2026 - Discusses a newly funded research project investigating effective methods of nicotine use prevention among rural Arkansas teens. Describes high rates of tobacco use in teens across the state.
Source: Arkansas Democrat-Gazette
Oct 29, 2026 - The Mountain Plains Rural Opioid Technical Assistance Center (MP ROTAC) is seeking feedback on the training, technical assistance, and support needs related to opioid, stimulant, and other substance use challenges impacting communities throughout the Mountain Plains region. Eligible stakeholders can submit feedback through November 15th, 2026.
SAMHSA: Agency Information Collection Activities: Proposed Collection; Comment Request
Federal Register
Oct 9, 2026 - Notice from the Substance Abuse and Mental Health Services Administration (SAMHSA) seeking comments on the extension of a generic clearance to conduct qualitative research to gain a better understanding of emerging substance use and mental health policy issues; improve the development and quality of instruments; and ensure SAMHSA leadership, centers, and offices have recent data and information for program and policy decision-making. Comments are due by December 8, 2026.
Source: Federal Register
SAMHSA: Agency Information Collection Activities Comment Request
Federal Register
Oct 8, 2026 - Notice from the Substance Abuse and Mental Health Services Administration (SAMHSA) seeking comments on proposed revisions to the National Substance Use and Mental Health Services Survey (N-SUMHSS), which collects information on the substance use and mental health treatment facility locations, characteristics, and use of substance use and mental health treatment services. Proposed changes include revising the questionnaire's content on crisis services and faith-based organizations, and targeted clarifications to existing N-SUMHSS questionnaire items. Comments are due by December 7, 2026.
Source: Federal Register
Sep 25, 2026 - Announces awarded funding for the Rural Communities Opioid Response Program (RCORP) which expands substance use disorder prevention, treatment, and recovery services throughout rural communities.
Source: Health Resources & Services Administration
Sep 21, 2026 - Describes disparities in buprenorphine treatment availability in rural areas despite new data showing a national increase in the medication in pharmacies and emergency departments. Discusses challenges that continue to exist in rural Pennsylvania and highlights telehealth as a tool that could support improved access to the medication.
Source: WHYY
Sep 17, 2026 - Describes transportation access issues in Kansas for people experiencing mental health or substance use crises. The state's Rural Health Transportation Program is seeking applicants to create a statewide mental health transportation system.
Source: Kansas Public Radio
SAMHSA: Agency Information Collection Activities: Proposed Collection; Comment Request
Federal Register
Sep 17, 2026 - The Substance Abuse and Mental Health Services Administration (SAMHSA) is seeking comments on proposed revisions to the National Survey on Drug Use and Health (NSDUH). Among other things, proposed updates for the 2027 NSDUH include revisions and additions to the Special Drugs module to prevent inconsistent reporting of last use of specific drugs with earlier modules; addition to the Mental Health Services Utilization module to capture past 12-month use of a Crisis Line service; and additions to the Emerging Issues module to measure past 12-month use of glucagon-like peptide-1 medications (GLP-1s), selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), mood stabilizers, and antipsychotic medications. Comments are due by November 16, 2026.
Source: Federal Register

